Prior to that, DeepHealth acquired Kheiron Medical Technologies, a U.K.-based mammography AI developer, for $2.3 million.

The Group's annual sales are up 110% compared to 2023 (excluding milestone payment), reaching €5.5 million, 53% of which comes from sales of Kheiron system implants combined with K-Rods custom ...

Read more about diversity in the technology sector The wage offered to women for tech jobs in the UK is 2.8% less than offered to male counterparts – a larger gap than in the US and Canada, says ...

For many years, cloned ponies have excelled in the prestigious equestrian sport of polo, and the sport has now taken a further step into equine technology, with the birth of the first genetically ...

Scientists in the polo-obsessed nation have produced world's first genetically edited horses, designed to outrun champion mare whose DNA they (mostly) share ...

Scientists at Argentine biotech firm Kheiron have produced the world’s first genetically edited horses using a technique called CRISPR-Cas9. The horses were born last October and November.

The team, at Argentine biotech firm Kheiron, used CRISPER-Cas9, a technique used to genetically modify organisms, to develop the world’s first genetically modified horses. "We design their genome ...

Scientists at Argentine biotech firm Kheiron have produced the world's first genetically edited horses using a technique called CRISPR-Cas9. The horses were born last October and November.

Scientists at Argentine biotech firm Kheiron have produced the world's first genetically edited horses using a technique called CRISPR-Cas9. The horses were born last October and November.

Argentina's award-winning mare Polo Pureza will have her genes, or at least most of them, live on in five genetically edited horses designed to outrun the polo legend herself.

Published by Philippine de Sortiraparis · Published on January 27, 2025 at 09:32 a.m. Comedian and actor Kheiron unveils his first play, Alba et Sadaf, an intriguing and daring creation.

Late last month, DeepHealth announced that it acquired the U.K.-based AI developer Kheiron Medical Technologies, with its own mammography-focused slate of CE marked programs.